Next Article in Journal
Synthesis and Evolution of Berberine Derivatives as a New Class of Antiviral Agents against Enterovirus 71 through the MEK/ERK Pathway and Autophagy
Previous Article in Journal
Morphological, Release and Antibacterial Performances of Amoxicillin-Loaded Cellulose Aerogels
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
Molecules 2018, 23(8), 2083; https://doi.org/10.3390/molecules23082083

Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor

1
College of Pharmacy, Dongguk University, Goyang 10326, Korea
2
School of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea
3
Hepatitis Research Laboratory, Department of Applied Molecular Virology, Institut Pasteur Korea, 696, Seongnam 13488, Korea
These authors equally contributed to this work.
*
Authors to whom correspondence should be addressed.
Received: 19 June 2018 / Revised: 1 August 2018 / Accepted: 11 August 2018 / Published: 20 August 2018
Full-Text   |   PDF [6667 KB, uploaded 20 August 2018]   |  

Abstract

Diacylglycerol acyltransferases (DGATs) play a critical role in the biosynthesis of endogenous triglycerides (TGs) and formation of lipid droplets (LDs) in the liver. In particular, one member of DGATs, DGAT-1 was reported to be an essential host factor for the efficient production of hepatitis C virus (HCV) particles. By utilizing our previously characterized three different groups of twelve DGAT inhibitors, we found that one of the DGAT inhibitors, a 2-((4-adamantylphenoxy) methyl)-N-(furan-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxam (10j) is a potent suppressor of both HCV genome replication and particle production. 10j was able to induce inhibition of these two critical viral functions in a mutually separate manner. Abrogation of the viral genome replication by 10j led to a significant reduction in the viral protein expression as well. Interestingly, we found that its antiviral effect did not depend on the reduction of TG biosynthesis by 10j. This suggests that the inhibitory activity of 10j against DGATs may not be directly related with its antiviral action. View Full-Text
Keywords: hepatitis C virus (HCV); diacylglycerol acyltransferase (DGAT); lipid droplet (LD); DGAT inhibitor; HCV genome replication; HCV particle production hepatitis C virus (HCV); diacylglycerol acyltransferase (DGAT); lipid droplet (LD); DGAT inhibitor; HCV genome replication; HCV particle production
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kim, D.; Goo, J.-I.; Kim, M.I.; Lee, S.-J.; Choi, M.; Than, T.T.; Nguyen, P.H.; Windisch, M.P.; Lee, K.; Choi, Y.; Lee, C. Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor. Molecules 2018, 23, 2083.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top